aaa

Staff exchange programme

An international and multidisciplinary staff exchange programme from 23 partners in 8 Eu/non-Eu countries

Newborn screening, diagnosis and treatment of sickle cell disease

Newborn screening, early diagnosis and appropriate treatments will improve patients’ quality of life.

Collaborative research and training initiatives

Different educational initiatives will be promoted to foster scientific cooperation and build research capacity.

Arise Project

African Research and Innovative Initiative for Sickle cell Education:
Improving Research Capacity for Service Improvement

ARISE is a research project recently funded by the EU in the framework of the H2020-MSCA-RISE-2018 programme aimed at creating an interagency and multidisciplinary staff exchange programme between experienced researchers, early start investigators and other relevant staff members of the partners institutions to share and spread the best practices in Newborn Screening, diagnosis and treatment of the Sickle Cell Disease, leading to improvement in overall disease outcome.

Arise Project

What is the
Sickle Cell Disease (SCD)

The Sickle Cell Disease (SCD) is a group of inherited red blood cells disorders. People who have sickle cell disease have an abnormal protein in their red blood cells.
This is a disease until a few decades ago almost unknown in Europe, and now is considered one of the most relevanthematological emergencies.

Latest News & Events

Keep updated on all the initiatives and events of the ARISE project

Save the date: COVID-19 and Sickle Cell Disease: the current scenario – session 2

Save the date: COVID-19 and Sickle Cell Disease: the current scenario – session 2

The second session of the webinar, to be held on Thursday 28th May, 2020 at 04:00 PM (UK time), will be the occasion to discuss with some relevant experts in the field who will provide their experience in order to understand the impact of COVID-19 on the SCD population, drawing conclusions from both the US and Lebanon. The emotional impact of the disease and the current response of the community in the US will be addressed as well.

read more
Save the date: COVID-19 and Sickle Cell Disease: the current scenario – session 1

Save the date: COVID-19 and Sickle Cell Disease: the current scenario – session 1

We are pleased to invite you to join the webinar “COVID-19 and Sickle Cell Disease: the current scenario”, organised within the ARISE project.  The first session of the webinar will be held on Tuesday 19th May, 2020 at 04:00 PM (UK time).  Relevant experts in the field of the haemoglobinopathies will give their contribution to understand the impact of the COVID-19 on the Sickle Cell Disease population and to compare the current pandemic response from the UK, Italy and Ghana, outlining the lessons learnt. 

read more

from the blog

Learn more about ARISE project